Skip to main content
. 2019 Feb 28;9:3154. doi: 10.1038/s41598-019-39102-8

Figure 2.

Figure 2

Ang-(1-7) does not influence BBB breakdown 24 hr post MCAO. (a,b) Gd-DTPA enhancement volume across the ipsilateral hemisphere did not differ between Ang-(1-7) (1.1 nmol/hr; n = 11) and control rats (aCSF; n = 12). (c) Ang-(1-7) therapy (n = 15) did not alter hemispheric swelling volume compared to Vehicle (aCSF; n = 13). (d) Gene expression levels for BBB breakdown marker, Mmp9, were significantly upregulated in MCAO vehicle group (n = 7) and nearly reaching significance in Ang-(1-7) treated rats (n = 7) compared to sham rats (n = 6). Ang-(1-7) did not alter Mmp9 mRNA levels compared to vehicle treated rats. (e) Gene expression values for Mmp9 inhibitor, Timp1, were significantly upregulated in MCAO groups (n = 7 per group) compared to sham animals (n = 6) without Ang-(1-7) induced effects compared to control. (f,g) Ang-(1-7) ICV therapy (n = 15) for 24 hr did not alter infarct volume in comparison to vehicle treated rats (n = 13). Data are presented as mean ± S.D. *P < 0.05; ***P < 0.001; unpaired Student’s t test. Gene expression data were compared using one-way ANOVA with Tukey’s posthoc test; *P < 0.05; ***P < 0.001 compared to sham.